LATEST NEWS | 17th Oct 2020 Anteris Technologies CEO hails 'very good results' from DurAVR™ human study

17th Oct 2020

Anteris Technologies CEO hails 'very good results' from DurAVR™ human study

25th Sep 2020

CEO Wayne Paterson is interviewed by 180 Markets

10th Aug 2020

DurAVR™ Key Opinion Leader Summary

9th Aug 2020

TAVR Key Opinion Leader Symposium

Latest News

Anteris Technologies CEO hails 'very good results' from DurAVR™ human study

CEO Wayne Paterson is interviewed by Proactive Investors

17th Oct 2020

CEO Wayne Paterson is interviewed by 180 Markets

CEO Wayne Paterson is interviewed by 180 Markets

25th Sep 2020

The New Daily Podcast by John Elder with Prof Leon Neethling & Wayne Paterson

Anteris an Australian company’s innovative bid to transform heart valve technology

13th Sep 2020

DurAVR™ Key Opinion Leader Summary

DurAVR™ Key Opinion Leader Summary

10th Aug 2020

TAVR Key Opinion Leader Symposium

Full Video & CEO Presentation Deck

9th Aug 2020

Credit Suisse Research Note

U.S. Medical Supplies & Devices TAVR KOL Symposium: Insights on Durability and the Future of TAVR Credit Suisse Research Note

22nd Jul 2020

CEO Wayne Paterson is interviewed by Ausbiz

The $5 billion market for valves to treat aortic stenosis, the most common heart valve disease, has the potential to double by 2025. CEO of Anteris Technologies, Wayne Paterson, was live with us and says the key points of difference for the Anteris valve are the anti-calcification feature and unique design. This innovation avoids the need for open-heart surgery, reducing the amount of time it requires for a patient to recover.

21st Jul 2020

Bioshares July 2020 Report

Anteris Technologies TAVR Advisory Board Signals High Level Interest

19th Jul 2020

Anteris Technologies delivering on its goals despite pandemic

Anteris Technologies Ltd's (ASX:AVR) Wayne Paterson tells Proactive's Andrew Scott the recent name change from Admedus is to reflect the single focus they have on structural heart and leveraging its assets into much more higher-value propositions. Paterson updates on its main trials which are underway and says he's extremely thrilled with the results to date from its first-in-human study. Paterson's expecting the company will end the year achieving all milestones set for 2020.

5th Jul 2020

ShareCafe's Hidden Gems Webinar – Anteris (AVR)

Latest video outlining Anteris direction to build the World's Most Durable Heart Valve

15th Jun 2020

StockPal Interview with Wayne Paterson

Anteris Technologies (ASX:AVR) – Wayne Paterson

4th Jun 2020

Bioshares - Admedus Name Change

Admedus has changed its name to Anteris Technologies

31st May 2020